ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 8, 2010, Pages 850-854

  Whyteside, A R ^a   Hinsley, E E ^a   Lambert, L A ^a   McDermott, P J ^a   Turner, A J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Endothelin converting enzyme 1; FAK; Phosphorylation; Prostate cancer

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; FOCAL ADHESION KINASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER CELL CULTURE; CELL COMPARTMENTALIZATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MEDIATOR; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROMA CELL;

ASPARTIC ACID ENDOPEPTIDASES; CELL LINE, TUMOR; ENDOTHELIN-1; FOCAL ADHESION KINASE 1; GENE EXPRESSION; HUMANS; ISOENZYMES; MALE; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEPRILYSIN; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 78650190274     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-054     Document Type: Article

References (24)

1. Bagnato, A., and Catt, K.J. 1998. Endothelins as autocrine regulators of tumor cell growth. Trends Endocrinol. Metab. 9(9): 378-383. doi:10.1016/S1043-2760(98)00094-0. PMID:18406309.
2. Berger, Y., Dehmlow, H., Blum-Kaelin, D., Kitas, E.A., Loffler, B.M., Aebi, J.D., and Juillerat-Jeanneret, L. 2005. Endothelinconverting enzyme-1 inhibition and growth of human glioblastoma cells. J. Med. Chem. 48(2): 483-498.doi:10.1021/jm040857x. PMID:15658862.
3. Dai, J., Shen, R., Sumitomo, M., Goldberg, J.S., Geng, Y., Navarro, D., et al. 2001. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin. Cancer Res. 7(5): 1370-1377. PMID:11350908.
4. Dawson, L.A., Maitland, N.J., Turner, A.J., and Usmani, B.A. 2004. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. Br. J. Cancer, 90(8): 1577-1582.doi:10.1038/sj.bjc. 6601717. PMID:15083188.
5. Debes, J.D., and Tindall, D.J. 2004. Mechanisms of androgen-refractory prostate cancer. N. Engl. J. Med. 351(15): 1488-1490. doi:10.1056/NEJMp048178. PMID:15470210.
6. Lambert, L.A., Whyteside, A.R., Turner, A.J., and Usmani, B.A. 2008. Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion. Br. J. Cancer, 99(7): 1114-1120. doi:10.1038/sj.bjc.6604631. PMID: 18781169.
7. Nelson, J.B., and Carducci, M.A. 2000. Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer. Cancer Invest. 18(1): 87-96. doi:10.3109/07357900009023066. PMID:10701371.
8. Nelson, J.B., Hedican, S.P., George, D.J., Reddi, A.H., Piantadosi, S., Eisenberger, M.A., and Simons, J.W. 1995. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. 1(9): 944-949. doi:10.1038/ nm0995-944. PMID:7585222.
9. Owens, L.V., Xu, L., Craven, R.J., Dent, G.A., Weiner, T.M., Kornberg, L., et al. 1995. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55(13): 2752-2755. PMID:7796399.
10. Owens, L.V., Xu, L., Dent, G.A., Yang, X., Sturge, G.C., Craven, R.J., and Cance, W.G. 1996. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 3(1): 100-105.doi:10.1007/BF02409059. PMID:8770310.
11. Papandreou, C.N., Usmani, B., Geng, Y., Bogenrieder, T., Freeman, R., Wilk, S., et al. 1998. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat. Med. 4(1): 50-57.doi:10. 1038/nm0198-050. PMID:9427606.
12. Parsons, J.T. 2003. Focal adhesion kinase: the first ten years. J. Cell Sci. 116(8): 1409-1416. doi:10.1242/jcs.00373. PMID: 12640026.
13. Rayhman, O., Klipper, E., Muller, L., Davidson, B., Reich, R., and Meidan, R. 2008. Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells. Cancer Res. 68(22): 9265-9273. doi:10.1158/0008-5472.CAN-08-2093. PMID:19010899.
14. Schaller, M.D., Hildebrand, J.D., Shannon, J.D., Fox, J.W., Vines, R.R., and Parsons, J.T. 1994. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14(3): 1680-1688.PMID:7509446.
15. Schweizer, A., Valdenaire, O., Nelbock, P., Deuschle, U., Dumas Milne Edwards, J.B., Stumpf, J.G., and Loffler, B.M. 1997. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem. J. 328(3): 871-877. PMID:9396733.
16. Smollich, M., Gotte, M., Yip, G.W., Yong, E.S., Kersting, C., Fischgräbe, J., et al. 2007. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer. Breast Cancer Res. Treat. 106(3): 361-369.doi:10.1007/s10549-007-9516-9. PMID:17295044.
17. Sumitomo, M., Shen, R., Walburg, M., Dai, J., Geng, Y., Navarro, D., et al. 2000. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J. Clin. Invest. 106(11): 1399-1407.doi:10.1172/JCI10536. PMID:11104793.
18. Sumitomo, M., Milowsky, M.I., Shen, R., Navarro, D., Dai, J., Asano, T., et al. 2001. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Cancer Res. 61(8): 3294-3298. PMID:11309283.
19. Sumitomo, M., Asano, T., Asakuma, J., Asano, T., Nanus, D.M., and Hayakawa, M. 2004a. Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase. Clin. Cancer Res. 10(1 Pt. 1): 260-266. doi:10.1158/1078-0432.CCR-0798-3. PMID:14734478.
20. Sumitomo, M., Iwase, A., Zheng, R., Navarro, D., Kaminetzky, D., Shen, R., et al. 2004b. Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell, 5(1): 67-78. doi:10.1016/S1535-6108(03)00331-3. PMID: 14749127.
21. Turner, A.J., Isaac, R.E., and Coates, D. 2001. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays, 23(3): 261-269. doi:10.1002/1521-1878(200103) 23:3<261::AID-BIES1036>3.0.CO;2-K. PMID:11223883.
22. Usmani, B.A., Harden, B., Maitland, N.J., and Turner, A.J. 2002. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clin. Sci. (Lond.), 103(Suppl. 48): 314S-317S. PMID:12193112.
23. Valdenaire, O., Lepailleur-Enouf, D., Egidy, G., Thouard, A., Barret, A., Vranckx, R., et al. 1999. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur. J. Biochem. 264(2): 341-349. doi:10.1046/j.1432-1327.1999. 00602.x. PMID:10491078.
24. Zhao, J., and Guan, J.L. 2009. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 28(1-2): 35-49. doi:10.1007/s10555-008-9165-4. PMID:19169797.